Alaunos Therapeutics (TCRT)

P/S ratio as of December 2024 (TTM): 552

According to Alaunos Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.22. At the end of 2024 the company had a P/S ratio of 830.

P/S ratio history for Alaunos Therapeutics from 2009 to 2024

PS ratio at the end of each year

Year	P/S ratio	Change
2024	830	-75.61%
2023	> 1000	6271.01%
2022	53.4	-90.98%
2021	592
2020	N/A
2019	N/A	-100%
2018	> 1000	2142.6%
2017	92.0	-10.45%
2016	103	-59.35%
2015	253	-34.49%
2014	386	-29.02%
2013	543	25.54%
2012	433	-4.36%
2011	453
2010	N/A
2009	N/A

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Alaunos Therapeutics (TCRT)